1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow B ALL: new trials by email Literature Review of B ALL trials Research Report on B ALL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-centric Study Epratuzumab - B ALL, CD22+ Expression | Phase 2 | Completed | Nantes University Hospital | 57 | 2010-11-01 | 2026-09-14 |
epratuzumab (1)
Nantes University Hospital (1)
France (1)